Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further reduce the number of injections in pediatric immunization schedules of countries currently using pentavalent DTaP combination vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Nicola P., Abu-Elyazeed, Remon, Cheuvart, Brigitte, Janssens, Winnie, Mesaros, Narcisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605854/
https://www.ncbi.nlm.nih.gov/pubmed/30444673
http://dx.doi.org/10.1080/21645515.2018.1549449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605854/
https://www.ncbi.nlm.nih.gov/pubmed/30444673
http://dx.doi.org/10.1080/21645515.2018.1549449

Ejemplares similares